Theodore J. Cory

1.5k total citations
42 papers, 1.2k citations indexed

About

Theodore J. Cory is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Theodore J. Cory has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 19 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Theodore J. Cory's work include HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (10 papers). Theodore J. Cory is often cited by papers focused on HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (10 papers). Theodore J. Cory collaborates with scholars based in United States and China. Theodore J. Cory's co-authors include David J. Feola, Santosh Kumar, Brian S. Murphy, Don Hayes, Courtney V. Fletcher, Susan E. Birket, Michael Anstead, Timothy W. Schacker, Mario Stevenson and Ying Mu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Theodore J. Cory

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Theodore J. Cory United States 19 336 309 265 227 195 42 1.2k
Alberto Bergamini Italy 24 371 1.1× 279 0.9× 407 1.5× 299 1.3× 309 1.6× 93 1.8k
Ingvild Nordøy Norway 20 300 0.9× 342 1.1× 589 2.2× 177 0.8× 437 2.2× 48 1.9k
Alagarraju Muthukumar United States 18 351 1.0× 125 0.4× 309 1.2× 183 0.8× 120 0.6× 36 999
Monica Basso Italy 19 174 0.5× 108 0.3× 292 1.1× 130 0.6× 421 2.2× 62 1.3k
Elizabeth Röth Hungary 17 737 2.2× 223 0.7× 84 0.3× 720 3.2× 236 1.2× 52 1.5k
Jieliang Li China 26 145 0.4× 430 1.4× 486 1.8× 226 1.0× 323 1.7× 78 2.0k
Yu He China 21 172 0.5× 376 1.2× 98 0.4× 54 0.2× 189 1.0× 73 1.2k
Tjomme van der Bruggen Netherlands 19 144 0.4× 306 1.0× 406 1.5× 65 0.3× 189 1.0× 37 1.3k
Edson Assis Brazil 14 387 1.2× 320 1.0× 444 1.7× 40 0.2× 404 2.1× 20 1.5k
Rebeca Alonso‐Arias Spain 22 145 0.4× 309 1.0× 679 2.6× 69 0.3× 372 1.9× 57 1.6k

Countries citing papers authored by Theodore J. Cory

Since Specialization
Citations

This map shows the geographic impact of Theodore J. Cory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore J. Cory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore J. Cory more than expected).

Fields of papers citing papers by Theodore J. Cory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore J. Cory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore J. Cory. The network helps show where Theodore J. Cory may publish in the future.

Co-authorship network of co-authors of Theodore J. Cory

This figure shows the co-authorship network connecting the top 25 collaborators of Theodore J. Cory. A scholar is included among the top collaborators of Theodore J. Cory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodore J. Cory. Theodore J. Cory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cory, Theodore J., et al.. (2024). Drug–drug interactions in HIV-infected patients receiving chemotherapy. Expert Opinion on Drug Metabolism & Toxicology. 21(1). 15–27. 2 indexed citations
2.
Cory, Theodore J., et al.. (2023). Substances of abuse and their effect on SAR-CoV-2 pathogenesis. PubMed Central. 2(3). 301–316. 1 indexed citations
3.
Cory, Theodore J., et al.. (2021). Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1. Frontiers in Immunology. 12. 733921–733921. 23 indexed citations
4.
Burns, Leah, Yuqing Gong, Kaining Zhi, et al.. (2020). An update on drug–drug interactions between antiretroviral therapies and drugs of abuse in HIV systems. Expert Opinion on Drug Metabolism & Toxicology. 16(11). 1005–1018. 18 indexed citations
5.
6.
Kodidela, Sunitha, Yujie Wang, Benjamin J. Patters, et al.. (2019). Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers. Journal of Neuroimmune Pharmacology. 15(3). 501–519. 37 indexed citations
7.
Hatami, Elham, Ying Mu, Subhash C. Chauhan, et al.. (2019). Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting. Biochemistry and Biophysics Reports. 17. 197–207. 62 indexed citations
8.
He, Hui, et al.. (2018). Polarized macrophage subsets differentially express the drug efflux transporters MRP1 and BCRP, resulting in altered HIV production. Antiviral chemistry & chemotherapy. 26. 2662864656–2662864656. 16 indexed citations
9.
Gong, Yuqing, et al.. (2018). The role of cytochrome P450 2E1 on ethanol-mediated oxidative stress and HIV replication in human monocyte-derived macrophages. Biochemistry and Biophysics Reports. 17. 65–70. 11 indexed citations
10.
Cory, Theodore J., Ying Mu, Yuqing Gong, Sunitha Kodidela, & Santosh Kumar. (2018). Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection. Expert Opinion on Pharmacotherapy. 19(7). 749–757. 8 indexed citations
11.
Mu, Ying, Sunitha Kodidela, Yujie Wang, Santosh Kumar, & Theodore J. Cory. (2018). The dawn of precision medicine in HIV: state of the art of pharmacotherapy. Expert Opinion on Pharmacotherapy. 19(14). 1581–1595. 13 indexed citations
12.
Midde, Narasimha M., et al.. (2016). Investigational protease inhibitors as antiretroviral therapies. Expert Opinion on Investigational Drugs. 25(10). 1189–1200. 27 indexed citations
13.
Midde, Narasimha M., Namita Sinha, Benjamin J. Patters, et al.. (2016). Effect of Polyaryl Hydrocarbons on Cytotoxicity in Monocytic Cells: Potential Role of Cytochromes P450 and Oxidative Stress Pathways. PLoS ONE. 11(9). e0163827–e0163827. 37 indexed citations
14.
Cory, Theodore J., et al.. (2015). Investigational reverse transcriptase inhibitors for the treatment of HIV. Expert Opinion on Investigational Drugs. 24(9). 1219–1228. 12 indexed citations
15.
Cory, Theodore J., Lee C. Winchester, Brian L. Robbins, & Courtney V. Fletcher. (2015). A Rapid Spin Through Oil Results in Higher Cell-Associated Concentrations of Antiretrovirals Compared with Conventional Cell Washing. Bioanalysis. 7(12). 1447–1455. 12 indexed citations
16.
Cory, Theodore J., Susan E. Birket, Brian S. Murphy, et al.. (2013). Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis. Journal of Cystic Fibrosis. 13(2). 164–171. 29 indexed citations
17.
Cory, Theodore J., Timothy W. Schacker, Mario Stevenson, & Courtney V. Fletcher. (2013). Overcoming pharmacologic sanctuaries. Current Opinion in HIV and AIDS. 8(3). 190–195. 109 indexed citations
18.
Cory, Theodore J., et al.. (2012). Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 68(4). 840–851. 14 indexed citations
19.
Murphy, Brian S., Heather Bush, Christina Davis, et al.. (2010). Characterization of macrophage activation states in patients with cystic fibrosis. Journal of Cystic Fibrosis. 9(5). 314–322. 56 indexed citations
20.
Fogarty, Barbara A., et al.. (2005). Rapid fabrication of poly(dimethylsiloxane)-based microchip capillary electrophoresis devices using CO2 laser ablation. The Analyst. 130(6). 924–924. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026